Exploring Stabilizing Amorphous Drugs
Welcome to our comprehensive guide on Stabilizing Amorphous Drugs.
- What are
- Drug molecules with poor water solubility or limited bioavailability present significant clinical challenges. One solution is to ...
- For more information, visit www.austinpx.com/kinetisol The KinetiSol™ Technology generates
- Dr. Frank Romanski speaks about the the role of excipient selection and key characteristics in
- The
In-Depth Information on Stabilizing Amorphous Drugs
Prof. Thomas Rades, University of Copenhagen, talks about polymers and small molecules in the process of Amorphous Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology ... For Dr. Frank Romanski, it is important to understand that solid
I caught up with Philippe to find out more about his upcoming presentation at DDF Summit North America next week about ASD ...
In summary, understanding Stabilizing Amorphous Drugs gives us a better perspective.